Tag: poster presentations

May 9, 2018

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...
April 25, 2018

Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial

Zogenix (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced additional...
November 21, 2017

DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting

DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, today provided...
May 24, 2017

SCYNEXIS Will Present New Data on Lead Candidate

SCYNEXIS announced it will present eight new poster presentations on the company's lead candidate SCY-078 at the ASM Microbe 2017.
April 5, 2017

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it...
April 4, 2017

Oncova Shows New Preclinical Data At Cancer Research Meeting

Onconova Therapeutics presented new preclinical findings for their dual inhibitor of CDK4/6 + ARK5, a Type 1 novel inhibitor of...
March 29, 2017

Marina Biotech To Show New Research At Cancer Meeting

Marina Biotech will showcase new scientific information on the use of IT-102 and IT-103 for cancer treatment during the American...